FIDSON HEALTHCARE PLC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.75 NGN | 0.00% |
|
+9.76% | -10.00% |
| Sales 2022 | 40.63B 28.93M 2.32B | Sales 2023 | 53.05B 37.77M 3.03B | Capitalization | 40.16B 28.6M 2.3B |
|---|---|---|---|---|---|
| Net income 2022 | 4.19B 2.98M 239M | Net income 2023 | 3.61B 2.57M 206M | EV / Sales 2022 | 0.82 x |
| Net Debt 2022 | 12.78B 9.1M 730M | Net Debt 2023 | 17.77B 12.65M 1.02B | EV / Sales 2023 | 1.09 x |
| P/E ratio 2022 |
4.93
x | P/E ratio 2023 |
11.1
x | Employees | 650 |
| Yield 2022 |
6.11% | Yield 2023 |
3.43% | Free-Float | 78.29% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | +9.76% | ||
| Current month | +9.76% | ||
| 1 month | -0.94% | ||
| 3 months | -6.25% | ||
| 6 months | +3.62% | ||
| Current year | -10.00% |
1 week
15.75
15.75
1 month
14.0015.90
Current year
13.6519.20
1 year
9.3019.20
3 years
4.1819.20
5 years
2.0119.20
10 years
0.8119.20
| Managers | Title | Age | Since |
|---|---|---|---|
Fidelis Ayebae
CEO | Chief Executive Officer | - | 31/12/94 |
Imokha Ayebae
DFI | Director of Finance/CFO | - | - |
Ola Ijimakin
BRD | Director/Board Member | - | 31/12/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 31/12/17 | |
Fidelis Ayebae
CEO | Chief Executive Officer | - | 31/12/94 |
| Director/Board Member | - | 31/12/00 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/05/24 | 15.75 | 0.00% | 82,377 |
| 07/05/24 | 15.75 | 0.00% | 14,776 |
| 06/05/24 | 15.75 | 0.00% | 158,863 |
| 03/05/24 | 15.75 | 0.00% | 255,643 |
| 02/05/24 | 15.75 | +9.76% | 362,796 |
End-of-day quote Nigerian S.E., May 07, 2024
More quotes
Fidson Healthcare specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of infectious, inflammatory, endocrinal, gastrointestinal, immune, metabolic, cardiovascular, oncological and central nervous system disorders. Net sales break down by activity as follows:
- sale of prescription medicines (70.7%) ;
- sale of OTC products (29.3%).
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.75
NGN
Average target price
22.47
NGN
Spread / Average Target
+42.67%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.00% | 25.92M | |
| +18.67% | 43.74B | |
| +21.99% | 22.26B | |
| +16.41% | 14.9B | |
| +9.03% | 13.39B | |
| +40.48% | 12.12B | |
| -9.64% | 6.92B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.41% | 5.47B |
- Stock Market
- Equities
- FIDSON Stock
